Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals-Reference-Cited by-同舟云学术

Preferential infection of human Ad5-specific CD4 T cells by HIV in Ad5 naturally exposed and recombinant Ad5-HIV vaccinated individuals

Published:2014-09-02 Issue:37 Volume:111 Page:13439-13444
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proc Natl Acad Sci USA

Author:

Hu Haitao,Eller Michael A.,Zafar Shah,Zhou Yu,Gu Mengnan,Wei Zhi,Currier Jeffrey R.,Marovich Mary A.,Kibuuka Hannah N.,Bailer Robert T.,Koup Richard A.,Robb Merlin L.,Michael Nelson L.,Kim Jerome H.,Ratto-Kim Silvia

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference30 articles.

1. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity

2. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

3. Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

4. Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

5. Extended Follow-up Confirms Early Vaccine-Enhanced Risk of HIV Acquisition and Demonstrates Waning Effect Over Time Among Participants in a Randomized Trial of Recombinant Adenovirus HIV Vaccine (Step Study)

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy-induced cytotoxic T follicular helper cells reduce numbers of retrovirus-infected reservoir cells in B cell follicles;PLOS Pathogens;2023-10-26

2. The use of adenoviral vectors in gene therapy and vaccine approaches;Genetics and Molecular Biology;2022

3. Immunogenicity of an inactivated SARS-CoV-2 vaccine in people living with HIV-1: a non-randomized cohort study;eClinicalMedicine;2022-01

4. Current approaches to HIV vaccine development: a narrative review;Journal of the International AIDS Society;2021-11

5. A Zigzag but Upward Way to Develop an HIV-1 Vaccine;Vaccines;2020-09-08